These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32226768)

  • 21. Mucopolysaccharidosis type I.
    Wraith JE; Jones S
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronal-specific impairment of heparan sulfate degradation in Drosophila reveals pathogenic mechanisms for Mucopolysaccharidosis type IIIA.
    Webber DL; Choo A; Hewson LJ; Trim PJ; Snel MF; Hopwood JJ; Richards RI; Hemsley KM; O'Keefe LV
    Exp Neurol; 2018 May; 303():38-47. PubMed ID: 29408731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Growth patterns in children with mucopolysaccharidosis type I-Hurler after hematopoietic stem cell transplantation: Comparison with untreated patients".
    Cattoni A; Chiaraluce S; Gasperini S; Molinari S; Biondi A; Rovelli A; Parini R
    Mol Genet Metab Rep; 2021 Sep; 28():100787. PubMed ID: 34408967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel conditional Sgsh knockout mouse model recapitulates phenotypic and neuropathic deficits of Sanfilippo syndrome.
    Lau AA; King BM; Thorsen CL; Hassiotis S; Beard H; Trim PJ; Whyte LS; Tamang SJ; Duplock SK; Snel MF; Hopwood JJ; Hemsley KM
    J Inherit Metab Dis; 2017 Sep; 40(5):715-724. PubMed ID: 28451919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracerebroventricular dosing of N-sulfoglucosamine sulfohydrolase in mucopolysaccharidosis IIIA mice reduces markers of brain lysosomal dysfunction.
    Magat J; Jones S; Baridon B; Agrawal V; Wong H; Giaramita A; Mangini L; Handyside B; Vitelli C; Parker M; Yeung N; Zhou Y; Pungor E; Slabodkin I; Gorostiza O; Aguilera A; Lo MJ; Alcozie S; Christianson TM; Tiger PMN; Vincelette J; Fong S; Gil G; Hague C; Lawrence R; Wendt DJ; Lebowitz JH; Bunting S; Bullens S; Crawford BE; Roy SM; Woloszynek JC
    J Biol Chem; 2022 Dec; 298(12):102625. PubMed ID: 36306823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan.
    Tanaka A; Okuyama T; Suzuki Y; Sakai N; Takakura H; Sawada T; Tanaka T; Otomo T; Ohashi T; Ishige-Wada M; Yabe H; Ohura T; Suzuki N; Kato K; Adachi S; Kobayashi R; Mugishima H; Kato S
    Mol Genet Metab; 2012 Nov; 107(3):513-20. PubMed ID: 23022072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sanfilippo syndrome in Turkey: Identification of novel mutations in subtypes A and B.
    Emre S; Terzioglu M; Tokatli A; Coskun T; Ozalp I; Weber B; Hopwood JJ
    Hum Mutat; 2002 Feb; 19(2):184-5. PubMed ID: 11793481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice.
    Gliddon BL; Hopwood JJ
    Pediatr Res; 2004 Jul; 56(1):65-72. PubMed ID: 15128919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late-onset mucopolysaccharidosis type IIIA mimicking Usher syndrome.
    De Falco A; Karali M; Criscuolo C; Testa F; Barillari MR; Scarpato M; Gaudieri V; Cuocolo A; Russo A; Nigro V; Simonelli F; Banfi S; Brunetti-Pierri N
    Am J Med Genet A; 2024 May; 194(5):e63517. PubMed ID: 38149346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Different Donors in Recipients With Mucopolysaccharidosis.
    Qu Y; Liu H; Wei L; Nie S; Ding W; Liu S; Liu H; Jiang H
    Front Pediatr; 2022; 10():877735. PubMed ID: 35844734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sanfilippo type A: new clinical manifestations and neuro-imaging findings in patients from the same family in Israel: a case report.
    Sharkia R; Mahajnah M; Zalan A; Sourlis C; Bauer P; Schöls L
    J Med Case Rep; 2014 Feb; 8():78. PubMed ID: 24576347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Residual activity and proteasomal degradation of p.Ser298Pro sulfamidase identified in patients with a mild clinical phenotype of Sanfilippo A syndrome.
    Muschol N; Pohl S; Meyer A; Gal A; Ullrich K; Braulke T
    Am J Med Genet A; 2011 Jul; 155A(7):1634-9. PubMed ID: 21671382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obstructive sleep apnea and craniofacial appearance in MPS type I-Hurler children after hematopoietic stem cell transplantation.
    Koehne T; Müller-Stöver S; Köhn A; Stumpfe K; Lezius S; Schmid C; Lukacs Z; Kahl-Nieke B; Muschol N
    Sleep Breath; 2019 Dec; 23(4):1315-1321. PubMed ID: 31332621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinal Degeneration in MPS-IIIA Mouse Model.
    Intartaglia D; Giamundo G; Marrocco E; Maffia V; Salierno FG; Nusco E; Fraldi A; Conte I; Sorrentino NC
    Front Cell Dev Biol; 2020; 8():132. PubMed ID: 32195255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemically modified recombinant human sulfamidase (SOBI003) in mucopolysaccharidosis IIIA patients: Results from an open, non-controlled, multicenter study.
    Harmatz P; Muenzer J; Ezgü F; Dalén P; Huledal G; Lindqvist D; Gelius SS; Wikén M; Önnestam K; Bröijersén A
    Mol Genet Metab; 2022 Aug; 136(4):249-259. PubMed ID: 35835061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation.
    Bjoraker KJ; Delaney K; Peters C; Krivit W; Shapiro EG
    J Dev Behav Pediatr; 2006 Aug; 27(4):290-6. PubMed ID: 16906003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Female mucopolysaccharidosis IIIA mice exhibit hyperactivity and a reduced sense of danger in the open field test.
    Langford-Smith A; Langford-Smith KJ; Jones SA; Wynn RF; Wraith JE; Wilkinson FL; Bigger BW
    PLoS One; 2011; 6(10):e25717. PubMed ID: 22028789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A).
    Meyer A; Kossow K; Gal A; Mühlhausen C; Ullrich K; Braulke T; Muschol N
    Pediatrics; 2007 Nov; 120(5):e1255-61. PubMed ID: 17938166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA.
    Crawley AC; Gliddon BL; Auclair D; Brodie SL; Hirte C; King BM; Fuller M; Hemsley KM; Hopwood JJ
    Brain Res; 2006 Aug; 1104(1):1-17. PubMed ID: 16828069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical, biochemical, and molecular characterization of mucopolysaccharidosis type III in 34 Egyptian patients.
    Almenabawy N; Ramadan M; Kamel M; Mahmoud IG; Amer F; Shaheen Y; Elnaggar W; Selim L
    Am J Med Genet A; 2023 Sep; 191(9):2354-2363. PubMed ID: 37596900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.